ArticleCancer cytopathology2022

Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma.

Zhonghua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.